Monoclonal Antibody Developability from Early Assay Panels: Machine Learning for Formulation and Pharmacokinetic Risk
Sabitoj Singh Virk, Akashdeep Singh Virk
This paper introduces ACeT, a machine learning framework that predicts formulation and pharmacokinetic risks of monoclonal antibodies using early assay panels, achieving high predictive accuracy and interpretability.
Machine Learning Health · Oct 3, 2026Peer-reviewedBioinformatics